Home
Knowledge Hub

Knowledge Hub

Featured content

Noble Advances Patient-Centered Innovation with New AI-Powered Sound Detection Patent

Starting with Curiosity: The Journey of Noble’s First Scholar

Noble Hosts Ceremony Celebrating Support for Redemption Home

01

Noble Advances Patient-Centered Innovation with New AI-Powered Sound Detection Patent

Noble Advances Patient-Centered Innovation with New AI-Powered Sound Detection Patent

As healthcare continues its shift toward home-based care and self-administration, ensuring patients can use complex drug delivery devices correctly has never been more important. To support this evolving landscape, Noble, an Aptar Pharma company, has been awarded a new U.S. patent for an artificial intelligence-enabled method that uses sound recognition technology to help determine whether a drug delivery or diagnostic device has been operated correctly.

Starting with Curiosity: The Journey of Noble’s First Scholar

Starting with Curiosity: The Journey of Noble’s First Scholar

On June 2, Noble welcomed its first-ever Noble Scholar, launching a new chapter in the company’s commitment to developing future talent.

Noble Hosts Ceremony Celebrating Support for Redemption Home

Noble Hosts Ceremony Celebrating Support for Redemption Home

At Noble, creating a positive impact extends beyond the healthcare solutions we provide. It also means supporting the communities where we live and work. Recently, Noble welcomed employees, community leaders, and representatives from Redemption Home to its Orlando headquarters for a special ceremony celebrating the organization’s mission of providing mentorship, stability, and opportunity for young men across Central Florida.

How Pharma Teams Should Approach Autoinjector Device Selection and Design Strategy

How Pharma Teams Should Approach Autoinjector Device Selection and Design Strategy

Learn how pharma teams should approach autoinjector device selection and autoinjector design strategy using patient-first insights, human factors, and real-world use to reduce risk and improve adherence.

From Innovation to Adoption: Why New GLP-1 Delivery Routes Require Human Factors and Training from Day One

From Innovation to Adoption: Why New GLP-1 Delivery Routes Require Human Factors and Training from Day One

GLP-1 therapies continue to transform the treatment landscape for obesity and type 2 diabetes. As innovation accelerates, so too does the evolution of how these therapies are delivered.

From Prescription to Persistence: How “Inside-Out” Patient Engagement Is Reshaping Specialty Pharma

From Prescription to Persistence: How “Inside-Out” Patient Engagement Is Reshaping Specialty Pharma

Discover how emerging “inside-out” patient engagement models are transforming specialty pharma by reducing drop-off, improving speed to therapy, and enabling proactive, data-driven support.